- Home
- NVCR vs HNI Comparison
NVCR vs HNI Comparison
Compare NVCR & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- HNI
- Stock Information
- Founded
- NVCR 2000
- HNI 1944
- Country
- NVCR Switzerland
- HNI United States
- Employees
- NVCR N/A
- HNI N/A
- Industry
- NVCR Medical/Dental Instruments
- HNI Office Equipment/Supplies/Services
- Sector
- NVCR Health Care
- HNI Consumer Discretionary
- Exchange
- NVCR Nasdaq
- HNI Nasdaq
- Market Cap
- NVCR 2.3B
- HNI N/A
- IPO Year
- NVCR 2015
- HNI N/A
- Fundamental
- Price
- NVCR $17.82
- HNI $44.35
- Analyst Decision
- NVCR Strong Buy
- HNI Strong Buy
- Analyst Count
- NVCR 4
- HNI 1
- Target Price
- NVCR $37.50
- HNI $63.00
- AVG Volume (30 Days)
- NVCR 795.3K
- HNI 465.0K
- Earning Date
- NVCR 05-01-2025
- HNI 04-28-2025
- Dividend Yield
- NVCR N/A
- HNI 2.98%
- EPS Growth
- NVCR N/A
- HNI 164.22
- EPS
- NVCR N/A
- HNI 2.88
- Revenue
- NVCR $605,220,000.00
- HNI $2,526,400,000.00
- Revenue This Year
- NVCR $3.41
- HNI $3.51
- Revenue Next Year
- NVCR $9.24
- HNI $3.75
- P/E Ratio
- NVCR N/A
- HNI $15.38
- Revenue Growth
- NVCR 18.82
- HNI 3.80
- 52 Week Low
- NVCR $11.70
- HNI $40.94
- 52 Week High
- NVCR $34.13
- HNI $58.42
- Technical
- Relative Strength Index (RSI)
- NVCR 33.96
- HNI 44.35
- Support Level
- NVCR $18.23
- HNI $42.67
- Resistance Level
- NVCR $19.06
- HNI $45.71
- Average True Range (ATR)
- NVCR 0.80
- HNI 0.95
- MACD
- NVCR 0.02
- HNI 0.29
- Stochastic Oscillator
- NVCR 5.57
- HNI 55.26
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.